Skip to main content
. 2020 Jul 13;28(e1):e72–e78. doi: 10.1136/ejhpharm-2020-002206

Table 5.

Therapeutic outcomes of drug-related problems during hospitalisation

Therapeutic outcome Intervention group Control group P value RRR or RBI
(95% CI)
NNT
(95% CI)
No of DRPs
N (%)
No of patients
N (%)
No of DRPs
N (%)
No of patients
N (%)
Number of DRPs during hospitalisation 545 63 517 60 NA NA
Resolved or improved 132 (24.2) 30 (47.6) 64 (12.4) 14 (23.3) 0.01 104.3% (RBI)
(20.5% to 245.6%)
4.1 (2.5 to 12.7)
Prevented 240 (44.0) 42 (66.7) 35 (6.8) 6 (10.0) <0.0001 567% (RBI)
(205.9% to 1352.8%)
1.8 (1.4 to 2.5)
Not changed 161 (29.5) 23 (36.5) 403 (77.9) 56 (93.3) <0.0001 60.9% (RRR)
(55.5% to 71.9%)
1.8 (1.4 to 2.3)
Worsened 12 (2.2) 6 (9.5) 15 (2.9) 12 (20.0) 0.71 52.5% (RRR)
(−18.8% to 80.9%)
9.5 (4.4 to 53.1)

DRP, drug-related problem; NNT, number needed to treat; RBI, relative benefit increase; RRR, relative risk reduction.